共 347 条
[61]
Willman CL(2006)Reduced intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years Blood 108 1092-1099
[62]
Godwin JE(2006)Nonablative versus reduced intensity conditioning regimens in the treatment of acute myeloid leukemia and high risk myelodysplastic syndrome: dose is relevant for long term disease control after allogeneic hematopoietic stem cell transplantation Blood 108 1092-1099
[63]
Grimwade D(2005)Prospective feasibility analysis of reduced intensity conditioning regimens for hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome J Clin Oncol 23 9387-9393
[64]
Walker H(2006)Is it appropriate to offer allogeneic hematopoietic stem cell transplantation to patients with refractory acute myeloid leukemia Bone Marrow Transplant 37 547-552
[65]
Harrison G(2006)Long term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced intensity conditioning for allogeneic stem cell transplantation Bone Marrow Transplant 37 339-344
[66]
Oliver F(1987)Control of advanced and refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced intensity conditioning for allogeneic stem cell transplantation Br J Haematol 67 397-406
[67]
Chatters S(2007)Allogeneic stem cell transplantation using a reduced intensity conditioning regimen has the capacity to produce durable remissions and ling term disease free survival in patients with high risk acute myeloid leukemia and myelodysplasia Biol Blood Marrow Transplant 13 10-undefined
[68]
Harrison CJ(2007)Outcome of reduced intensity allogeneic hematopoietic stem cell transplantation using antilymphocyte antibodies in patients with high risk acute myeloid leukemia Biol Blood Marrow Transplant 13 4-undefined
[69]
List AF(undefined)Reduced toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation in elderly patients with secondary acute myeloid leukemia or myelodysplastic syndrome undefined undefined undefined-undefined
[70]
Spier SC(undefined)Risk factors for acute graft versus host disease undefined undefined undefined-undefined